Investor Relations
Explore information about IDEAYA's business, strategy, pipeline, and financial performance, as well as the latest updates for the investment community.
Events
Guggenheim 3rd Annual Healthy Altitudes CEO Summit Panel
Participation by Yujiro Hata, Chief Executive Officer, IDEAYA Biosciences, moderated by Dan Skovronsky, M.D. Ph.D. CSO, Eli Lilly with host Seamus Fernandez, Senior Managing Director and Global Biopharma Analyst, Guggenheim Securities